MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..7 of 7 - per page
Order by
Small Molecule Inhibitors of c-Met
Novel small molecule inhibitors of c-Met signaling; these small molecules selectively bind to c-Met and have an IC50 in the micromolar range. More
Human Papillomavirus microRNA Diagnostics and Therapeutics
Uses of a p53 specific microRNA (miRNA): It has been reported that the tumor suppressive mRNA miR-34a (a downstream target of p53) is downregulated in HPV-infected primary keratinocytes. More
A Single Ribozyme to Catalyze both Trimming and Transacting Catalysis - Potential Therapeutic for HPV Infection and Cervical Cancer
Implementation of triplex systems that significantly enhance R434 in vitro activity is offered as an alternative to the antisense oligodeoxynucleotide treatment of cervical cancer More
Dominant CD8 T Cell Epitope that blocks infection by HPV (06-06 05-13)
Preventative vaccine, source of antigens for dendritic cell immunotherapy to treat cervical cancer More
Dominant CD4 T Cell Epitopes of Human Papilloma Virus and Uses for Comprehensive Vaccine Development (08-07)
Generation of new vaccines against rare epitopes of HPV to block viral infection and prevent cervical cancer. More
Dominant CD4 T Cell Epitopes of Human Papilloma Virus and Uses for Comprehensive Vaccine Development (08-06)
Potential to extend the development of vaccines against previous unavailable HPV viral types. More
Repeat Sequences of the CA125 Gene and Their Use for Diagnostic and Therapeutic Interventions (01-07) DCV
Cancer treatment, including vaccines, targets for immune stipulation, drug, or biological modifier delivery More
Displaying 1..7 of 7 - per page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Need competitive intelligence information
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us